FMO5 and infection: Treatment of PMs prior to infection with the NADPH oxidase inhibitor diphenyleneiodonium (DPI) inhibited release of METs, whereas treatment of uninfected macrophages with PMA resulted in similar levels of MET release to GBS-infected cells (Fig. 2A and B).